Cyberounds Logo
August 05, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
Pancreatic Adenocarcinoma
CME credit is no longer available for this conference.
Parvin Peddi, M.D., and Andrea Wang-Gillam, M.D.

Dr. Peddi is a hematology/oncology fellow and Dr. Wang-Gillam is an Assistant Professor, Washington University School of Medicine, St. Louis, MO

Within the past 12 months, Dr. Peddi and Dr. Wang-Gillam report no commercial conflict of interest.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.

Release Date: 08/13/2012
Termination Date: 08/13/2015

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Identify common risk factors for development of pancreatic cancer
  • Identify common presentation of pancreatic cancer and its staging
  • Apply common paradigms in the treatment of pancreatic cancer
  • Apply principles of palliation for symptoms of pancreatic cancer.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity